VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 63 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.55 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,919 | -30.2% | 36,461 | -5.3% | 0.00% | – |
| Q2 2023 | $54,301 | -11.8% | 38,511 | -0.5% | 0.00% | – |
| Q1 2023 | $61,547 | +13.0% | 38,709 | +3.7% | 0.00% | – |
| Q4 2022 | $54,487 | -65.7% | 37,320 | 0.0% | 0.00% | – |
| Q3 2022 | $159,000 | +22.3% | 37,320 | +11.3% | 0.00% | – |
| Q2 2022 | $130,000 | -90.2% | 33,527 | -88.0% | 0.00% | – |
| Q1 2022 | $1,326,000 | +23.8% | 278,626 | -5.1% | 0.00% | – |
| Q4 2021 | $1,071,000 | -55.8% | 293,492 | -2.8% | 0.00% | – |
| Q3 2021 | $2,422,000 | -31.9% | 302,096 | -3.6% | 0.00% | -100.0% |
| Q2 2021 | $3,554,000 | +2813.1% | 313,350 | +2273.5% | 0.00% | – |
| Q1 2021 | $122,000 | – | 13,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $421,314 | 0.28% |
| BVF INC/IL | 3,614,662 | $5,277,407 | 0.22% |
| Samsara BioCapital, LLC | 689,709 | $1,006,975 | 0.22% |
| Rubric Capital Management LP | 1,330,983 | $1,943,235 | 0.08% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $52 | 0.02% |
| MAI Capital Management | 426,916 | $623,297 | 0.01% |
| Jasper Ridge Partners, L.P. | 92,939 | $135,691 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $25,550 | 0.01% |
| RP Management, LLC | 3,700 | $5,402 | 0.01% |
| Laurion Capital Management LP | 698,000 | $1,019,080 | 0.01% |